BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2309000)

  • 41. Automated processing of human bone marrow grafts for transplantation.
    Zingsem J; Zeiler T; Zimmermanm R; Weisbach V; Mitschulat H; Schmid H; Beyer J; Siegert W; Eckstein R
    Vox Sang; 1993; 65(4):293-9. PubMed ID: 8310681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of non-cryopreservation on colony formation of committed progenitor cells of bone marrow.
    Tajima T
    Tokai J Exp Clin Med; 1988 Feb; 13(1):15-22. PubMed ID: 3068837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human bone marrow processing using Cobe 2991 and CS 3000 blood cell separators for further ex vivo manipulation.
    Angelini A; Dragani A; Iacone A; D'Antonio D; Accorsi P; Quaglietta AM; Berardi A; Fioritoni G; Di Bartolomeo P; D'Emilio G
    Haematologica; 1990; 75 Suppl 1():43-7. PubMed ID: 2351343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of different temperature of cryopreservation on the proliferative potential of human bone marrow progenitor cells. Transplantological implications.
    Ratajczak MZ; Kuczyński WI; Ratajczak J
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):217-21. PubMed ID: 7487356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-frozen preservation of committed hematopoietic stem cells from normal human bone marrow.
    Kohsaki M; Yanes B; Ungerleider JS; Murphy MJ
    Stem Cells (1981); 1981; 1(2):111-23. PubMed ID: 7348461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
    Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
    Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive factors for the rate of engraftment of neuroblastoma patients autotransplanted with purged marrow.
    Ross RE; Jeter EK; Gazitt Y; Laver J
    Prog Clin Biol Res; 1994; 389():139-43. PubMed ID: 7700896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Techniques of harvesting and cryopreservation of stem cells.
    Meagher RC; Herzig RH
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):501-33. PubMed ID: 8102133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation.
    Ciobanu N; Paietta E; Andreeff M; Papenhausen P; Wiernik PH
    Exp Hematol; 1986 Aug; 14(7):626-35. PubMed ID: 3525202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
    Ball ED; Keefe KA; McDermott JM
    Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
    Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
    Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolonged thrombocytopenia after autologous bone marrow transplantation].
    Kojima S; Fukuda M; Horibe K; Matsuyama T; Takeyama K; Matsushita T; Miyamura K; Sugihara T; Minami S; Kodera Y
    Rinsho Ketsueki; 1989 Feb; 30(2):175-80. PubMed ID: 2664261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experience with the use of different methods of bone marrow separation and cryopreservation at the bone marrow transplantation centers of the Regional Hospital of the City of Bolzano (Italy) and of the Saint Petersburg Institute of Hematology and Blood Transfusion].
    Moiseev SI; Kozer P; Prinot O; Gentelini I; Gritsaev SV; Abdulkadyrov KM
    Ter Arkh; 1994; 66(7):21-5. PubMed ID: 7985122
    [No Abstract]   [Full Text] [Related]  

  • 56. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.
    Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR
    Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Autologous bone marrow transplantation in solid tumors in children].
    Ohira M; Shibata T; Ise T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1428-37. PubMed ID: 6347080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
    Letheby B; Jackson J; Greally J; Warkentin P; Smith D; Vose J; Bierman P; Kessinger A; Coccia P; Armitage J
    Prog Clin Biol Res; 1992; 377():345-51. PubMed ID: 1279712
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone marrow processing for transplantation.
    Areman EM; Sacher RA
    Transfus Med Rev; 1991 Jul; 5(3):214-27. PubMed ID: 1687956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.